177Lu-IM-3050

· Immunome, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-IM-3050, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer [EARLY_Phase 1]